Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Breast cancer pill from AstraZeneca misses mark in pivotal trial
2+ hour, 48+ min ago (204+ words) STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories…...
What I learned going from doula to OB-GYN
1+ week, 2+ day ago (915+ words) Eluobaju is a maternal-fetal medicine fellow at Weill Cornell Medicine. I was standing in an operating room waiting impatiently for the abdominal prep to dry before an urgent cesarean delivery following a failed trial of labor after cesarean. The room…...
Novartis picks up experimental breast cancer drug for $2B
5+ mon, 3+ week ago (265+ words) LONDON — Novartis said Friday it was buying an experimental breast cancer drug from Delaware-based Synnovation Therapeutics for $2 billion upfront. The deal includes includes up to another $1 billion if the drug reaches certain milestones. The drug, an oral medicine called SNV4818, is…...
The question we need to ask about the maternal mortality crisis
9+ mon, 1+ week ago (624+ words) Weli is a public health advocate and cultural liaison based in Minnesota. Why now? I had three children without ever seeing a doctor. Why go looking for problems? That’s what Fatima, a 38-year-old Somali mother, said when I encouraged her…...
At ESMO, AstraZeneca and Gilead square off in triple-negative breast cancer
10+ mon, 3+ week ago (278+ words) Andrew is STAT's Europe correspondent, based in London. Before moving to the U.K. in 2023, he worked as a general assignment reporter in STAT's Boston headquarters, starting with its launch in 2015. He was part of the STAT team that was named a…...
Enhertu pushes into early breast cancer, as antibody-drug conjugates move up the line
10+ mon, 3+ week ago (246+ words) Andrew is STAT's Europe correspondent, based in London. Before moving to the U.K. in 2023, he worked as a general assignment reporter in STAT's Boston headquarters, starting with its launch in 2015. He was part of the STAT team that was named a…...
Roche, Celcuity detail successful advanced breast cancer studies
10+ mon, 3+ week ago (254+ words) Andrew is STAT's Europe correspondent, based in London. Before moving to the U.K. in 2023, he worked as a general assignment reporter in STAT's Boston headquarters, starting with its launch in 2015. He was part of the STAT team that was named a…...
New breast cancer screening trial may answer key AI question
11+ mon, 2+ week ago (323+ words) STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories…...